In today’s session Monsanto Company (MON) registered an unusually high (2,524) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the January, 2017 call, expecting serious MON increase. With 2,524 contracts traded and 166994 open interest for the Jan, 17 contract, it seems this is a quite bullish bet. The option with symbol: MON170120C00105000 closed last at: $1.31 or 95.5% up. About 410,271 shares traded hands. Monsanto Company (NYSE:MON) has risen 13.15% since April 18, 2016 and is uptrending. It has outperformed by 8.72% the S&P500.
Monsanto Company (NYSE:MON) Ratings Coverage
Out of 20 analysts covering Monsanto Company (NYSE:MON), 14 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 70% are positive. Monsanto Company has been the topic of 39 analyst reports since August 25, 2015 according to StockzIntelligence Inc. The firm earned “Buy” rating on Thursday, October 8 by UBS. The company was downgraded on Thursday, September 15 by CLSA. The firm has “Neutral” rating by Citigroup given on Friday, July 1. As per Monday, March 14, the company rating was downgraded by Citigroup. The company was maintained on Thursday, October 6 by Barclays Capital. The firm has “Buy” rating given on Thursday, September 15 by Deutsche Bank. Stifel Nicolaus maintained Monsanto Company (NYSE:MON) on Friday, October 9 with “Buy” rating. The rating was maintained by Piper Jaffray with “Overweight” on Thursday, August 27. Citigroup maintained Monsanto Company (NYSE:MON) rating on Thursday, April 7. Citigroup has “Neutral” rating and $94 price target. The rating was reinitiated by Goldman Sachs with “Neutral” on Wednesday, September 23.
According to Zacks Investment Research, “Monsanto is a leading global provider of technology-based solutions and agricultural products for growers and downstream customers, such as grain processors and consumers, in the agricultural markets. The combination of its herbicides, seeds and related genetic trait products provides growers with integrated solutions to more efficiently and cost effectively produce crops at higher yields, while controlling weeds, insects and diseases. Its base business, led by Roundup and coupled with the latest tools in biotechnology, genomics and molecular breeding.”
Insitutional Activity: The institutional sentiment increased to 1.02 in Q2 2016. Its up 0.11, from 0.91 in 2016Q1. The ratio improved, as 88 funds sold all Monsanto Company shares owned while 334 reduced positions. 142 funds bought stakes while 243 increased positions. They now own 338.57 million shares or 4.89% less from 355.97 million shares in 2016Q1.
Blackrock accumulated 1.26 million shares or 0.2% of the stock. Baldwin Investment Limited holds 2,450 shares or 0.11% of its portfolio. Teachers Retirement Of The State Of Kentucky holds 56,982 shares or 0.08% of its portfolio. The California-based Inv House Llc has invested 0.18% in Monsanto Company (NYSE:MON). Smith Asset Management Grp Inc Inc L P owns 109,153 shares or 0.34% of their US portfolio. Allen Invest Ltd Liability Co has 3.41% invested in the company for 425,027 shares. Nationwide Fund Advsr last reported 0.15% of its portfolio in the stock. Madison Investment Inc holds 64,039 shares or 0.14% of its portfolio. Lenox Wealth Management has invested 0.01% of its portfolio in Monsanto Company (NYSE:MON). Prudential Public Ltd Liability Com accumulated 0% or 7,313 shares. Estabrook has invested 0% of its portfolio in Monsanto Company (NYSE:MON). Pentwater Capital Management Limited Partnership, a Illinois-based fund reported 335,200 shares. M&T Bancorporation last reported 240,813 shares in the company. Ancora Advsr Limited Liability last reported 0.03% of its portfolio in the stock. The Michigan-based Ls Invest Advsrs Ltd has invested 0.09% in Monsanto Company (NYSE:MON).
Insider Transactions: Since October 10, 2016, the stock had 1 insider purchase, and 3 selling transactions for $8.18 million net activity. Another trade for 3,500 shares valued at $361,319 was bought by MCMILLAN CHARLES S. $8.23M worth of Monsanto Company (NYSE:MON) shares were sold by FRALEY ROBERT T. 2,745 Monsanto Company (NYSE:MON) shares with value of $277,145 were sold by Preete Kerry J. MIZELL STEVEN sold 310 shares worth $31,958.
Monsanto Company , along with its subsidiaries, is a well-known provider of agricultural products for farmers. The company has a market cap of $44.13 billion. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. It has a 33.56 P/E ratio. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
MON Company Profile
Monsanto Company (Monsanto), incorporated on February 9, 2000, along with its subsidiaries, is a well-known provider of agricultural products for farmers. The Firm provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Firm operates through two divisions: Seeds and Genomics, and Agricultural Productivity.
More important recent Monsanto Company (NYSE:MON) news were published by: Bloomberg.com which released: “Monsanto Talked to Three Other Companies Before Bayer Deal” on October 19, 2016, also Tucson.com published article titled: “Here are details about the tax deal Pima County could give Monsanto”, Reuters.com published: “Bayer to raise four billion euros via convertible notes for Monsanto deal” on November 15, 2016. More interesting news about Monsanto Company (NYSE:MON) was released by: Wsj.com and their article: “Bayer CEO Defends Planned Acquisition of Monsanto” with publication date: October 26, 2016.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.